Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research.

J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253. Erratum in: J Bone Miner Res. 2011 Aug;26(8):1987.

2.

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP.

J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1. Review.

3.

Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.

Adams AL, Xue F, Chantra JQ, Dell RM, Ott SM, Silverman S, Giaconi JC, Critchlow C.

Osteoporos Int. 2017 Jan;28(1):413-417. doi: 10.1007/s00198-016-3809-y. Epub 2016 Oct 21.

PMID:
27766369
4.

Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.

Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black DM.

J Clin Endocrinol Metab. 2012 Jul;97(7):2414-22. doi: 10.1210/jc.2011-3256. Epub 2012 Apr 30.

5.

Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.

Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y.

J Bone Miner Metab. 2012 Sep;30(5):561-7. doi: 10.1007/s00774-012-0358-0. Epub 2012 May 19.

PMID:
22610061
6.

Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.

Niikura T, Lee SY, Sakai Y, Kuroda R, Kurosaka M.

J Med Case Rep. 2015 May 6;9:103. doi: 10.1186/s13256-015-0590-z.

7.

Atypical Fractures are Mainly Subtrochanteric in Singapore and Diaphyseal in Sweden: A Cross-Sectional Study.

Schilcher J, Howe TS, Png MA, Aspenberg P, Koh JS.

J Bone Miner Res. 2015 Nov;30(11):2127-32. doi: 10.1002/jbmr.2547. Epub 2015 Jun 15.

8.

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.

Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH.

J Bone Miner Res. 2011 May;26(5):993-1001. doi: 10.1002/jbmr.288.

9.

Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.

Bissonnette L, April PM, Dumais R, Boire G, Roux S.

Bone. 2013 Oct;56(2):406-9. doi: 10.1016/j.bone.2013.07.012. Epub 2013 Jul 17.

PMID:
23871749
10.

Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.

Nieves JW, Cosman F.

Curr Osteoporos Rep. 2010 Mar;8(1):34-9. doi: 10.1007/s11914-010-0007-2. Review.

PMID:
20425089
11.
12.

Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.

Chang ST, Tenforde AS, Grimsrud CD, O'Ryan FS, Gonzalez JR, Baer DM, Chandra M, Lo JC.

Bone. 2012 Sep;51(3):524-7. doi: 10.1016/j.bone.2012.05.010. Epub 2012 May 23.

PMID:
22634175
13.

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

Lee JK.

Int J Rheum Dis. 2009 Jul;12(2):149-54. doi: 10.1111/j.1756-185X.2009.01396.x.

PMID:
20374333
14.

Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.

Warren C, Gilchrist N, Coates M, Frampton C, Helmore J, McKie J, Hooper G.

ANZ J Surg. 2012 Dec;82(12):908-12. doi: 10.1111/j.1445-2197.2012.06199.x. Epub 2012 Sep 3.

PMID:
22943522
15.

Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.

Eisenstein N, Kasavkar G, Bhavsar D, Khan FS, Paskins Z.

BMC Musculoskelet Disord. 2017 Jan 23;18(1):29. doi: 10.1186/s12891-017-1392-9.

16.

Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.

Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG.

J Bone Joint Surg Br. 2012 Mar;94(3):385-90. doi: 10.1302/0301-620X.94B3.27999.

PMID:
22371548
17.

Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.

Narongroeknawin P, Patkar NM, Shakoory B, Jain A, Curtis JR, Delzell E, Lander PH, Lopez-Ben RR, Pitt MJ, Safford MM, Volgas DA, Saag KG.

J Clin Densitom. 2012 Jan-Mar;15(1):92-102. doi: 10.1016/j.jocd.2011.09.001. Epub 2011 Nov 9.

18.
19.

Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Giusti A, Hamdy NA, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE.

Bone. 2011 May 1;48(5):966-71. doi: 10.1016/j.bone.2010.12.033. Epub 2010 Dec 31.

PMID:
21195812
20.

Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E; American Society for Bone and Mineral Research.

J Bone Miner Res. 2007 Oct;22(10):1479-91.

Supplemental Content

Support Center